Effects of Physical Exercise on Response to Treatement in Breast Cancer (CancerBeat)

Latvian Biomedical Research and Study Centre

Status: Active, not recruiting

Conditions: Breast Cancer

Treatments: Behavioral: High-intensiy interval training

Study type: Interventional

Funder types: Other

Identifiers

NCT06522971

NFI_164

Details and patient eligibility

About

The goal of this clinical trial is to learn how regular physical exercise affects breast cancer patients' response to standard neoadjuvant chemotherapy (NAC) and to gain an insight into the molecular mechanisms underlying the effects of exercise on cancer biology. of exercise-induced alterations in cancer gene expression and the immune tumor microenvironment. The main questions it aims to answer are:

• Does a high-intensity interval training (HIIT) program during treatment improve patients' response to NAC and quality of life as compared to low level of physical activity during the treatment?
• What are the differences in the residual tumor gene expression and tumor infiltrating immune cell profile between patients taking HIIT during the NAC and patients with low level of physical activity?
• What are the roles of extracellular vesicles (EVs) in mediating the effects of exercise on cancer progression?

Patients in HIIT group will undergo a personalized HIIT program consisting of 3 training sessions per week for the whole duration of NAC, whereas patients from the control group (Ctrl) will be advised to maintain their usual level of physical activity during NAC. After the breast surgery, response to NAC will be assessed by Miller-Payne grading. Tumor and normal breast tissue specimens will be collected for RNA sequencing analysis. Blood samples will be collected before and immediately after the training for the analysis of RNA and protein cargo of circulating EVs.

Enrollment: 55 patients

Sex: Female

Ages: 30 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Primary breast cancer; stage IIA-B, IIIA-C (TNM: T1-4, N0-3, M0) at diagnosis
• Diagnosis established by core needle biopsy
• Age 30-65 years
• Prescribed doxorubicin/cyclophosphamide-based NAC
• Oral and written consent

Exclusion criteria

• Cardiac pathologies
• Pregnancy
• Blood transfusion in the last six months
• Another oncological disease
• Previous chemotherapy, hormonal or X-ray treatment
• Participation in another clinical trial
• Currently performing more than 180 min of moderate to high intensity aerobic training per week

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

55 participants in 2 patient groups

High-intensity interval training (HIIT)

Experimental group

Description:

High-intensity interval training during neoadjuvant chemotherapy

Treatment:

Behavioral: High-intensiy interval training

Low level of physical activity (CON)

No Intervention group

Description:

Advised to maintain usual level of physical activity during neoadjuvant chemotherapy